Biotech

All Articles

Lykos will inquire FDA to reexamine its decision complying with denial of MDMA treatment for post-traumatic stress disorder

.Observing an inadequate revealing for Lykos Therapies' MDMA applicant for trauma at a current FDA a...

AN 2 one-halfs headcount, quits period 3 trial after data disappoint

.AN2 Rehabs is actually reviewing its company in feedback to lackluster midphase records, pledging t...

Merck pays $700M for bispecific, spying autoimmune opening and also chance to test Amgen in cancer cells

.Merck &amp Co. is spending $700 thousand upfront to test Amgen in a blood stream cancer cells marke...

Gilead pays out J&ampJ $320M to exit licensing offer for seladelpar

.With Gilead Sciences almost an FDA choice for its liver health condition medication seladelpar, the...

' All palms on deck' at Lilly as peers target being overweight market

.Chief executive officer David Ricks can easily view the companies putting together outdoors tents a...

Entero laying off personnel, abandoning workplace and stopping briefly R&ampD

.Mattress Liquidators has actually switched Entero Rehabs white as a piece. The creditor bought Ente...

Exelixis falls ADC after determining it is actually no match for Tivdak

.Exelixis is quiting on its cells factor (TF)- targeting antibody-drug conjugate after wrapping up t...

Relay loses interest in SHP2 inhibitor after Genentech leaves behind

.3 weeks after Roche's Genentech system bowed out an SHP2 inhibitor deal, Relay Rehab has validated ...

Stoke's Dravet syndrome med discharged of predisposed medical grip

.Stoke Rehabs' Dravet syndrome medicine has actually been actually freed from a predisposed grip, cl...

Fierce Biotech's Gabrielle Masson presents Ferocious 15 at NYSE

.Intense Biotech Affiliate Editor Gabrielle Masson provided the 2024 course of Strong 15 winners on ...